DAVID DANTZKER - 10 Feb 2022 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John Manders, on behalf of David R. Dantzker
Issuer symbol
SRDX
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:38:49 UTC
Previous filing
04 Jan 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Award $0 +1,375 +4.4% $0.000000 32,585 10 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Award $0 +3,555 $0.000000 3,555 10 Feb 2022 Common Stock 3,555 $41.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 11,985 restricted stock units (RSUs) that vest on service-based vesting dates and 15,415 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 The stock options vest ratably on a monthly basis and become fully vested on February 10, 2023, the 12-month anniversary of the grant date.